BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 6715167)

  • 1. [Skin changes in paraproteinemias (monoclonal gammopathies)].
    Merk H; Goerz G
    Hautarzt; 1984 Mar; 35(3):126-31. PubMed ID: 6715167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin disorders in association with monoclonal gammopathies.
    Harati A; Brockmeyer NH; Altmeyer P; Kreuter A
    Eur J Med Res; 2005 Mar; 10(3):93-104. PubMed ID: 15851375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cutaneous manifestations of paraproteinemia and their mechanisms].
    Lipsker D; Boeckler P
    Presse Med; 2007; 36(7-8):1135-40. PubMed ID: 17289338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic manifestations of monoclonal gammopathy.
    Decaux O; Laurat E; Perlat A; Cazalets C; Jego P; Grosbois B
    Eur J Intern Med; 2009 Sep; 20(5):457-61. PubMed ID: 19712843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scleredema adultorum associated with a monoclonal gammopathy and generalized hyperpigmentation.
    McFadden N; Ree K; Søyland E; Larsen TE
    Arch Dermatol; 1987 May; 123(5):629-32. PubMed ID: 3579342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloma, paraproteinemias, and the skin.
    Piette WW
    Med Clin North Am; 1986 Jan; 70(1):155-76. PubMed ID: 3001452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monoclonal immunoglobulin (M-Ig) and skin diseases from the group of mucinoses--scleredema adultorum Buschke and scleromyxedema. Description of four cases and an overview of therapies].
    Adam Z; Szturz P; Krejčí M; Vašků V; Pour L; Michalková E; Ševčíková S; Čermáková Z; Veselý K; Vaníček J; Pourová E; Král Z; Mayer J
    Vnitr Lek; 2015 Dec; 61(12):1072-87. PubMed ID: 26806503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Skin manifestations of monoclonal gammopathies].
    Hello M; Barbarot S; Néel A; Connault J; Graveleau J; Durant C; Decaux O; Hamidou M
    Rev Med Interne; 2014 Jan; 35(1):28-38. PubMed ID: 24070793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal gammopathy in scleredema. Observations in three cases.
    Kövary PM; Vakilzadeh F; Macher E; Zaun H; Merk H; Goerz G
    Arch Dermatol; 1981 Sep; 117(9):536-9. PubMed ID: 6794460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular disorders associated with paraproteinemia.
    Hoffman-Snyder C; Smith BE
    Phys Med Rehabil Clin N Am; 2008 Feb; 19(1):61-79, vi. PubMed ID: 18194750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal gammopathies].
    Fain O
    Rev Prat; 2006 Jan; 56(1):40-50. PubMed ID: 16548248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pyoderma gangrenosum with IgG-paraproteinemia in plasmacytoma].
    Zabel M
    Hautarzt; 1976 Dec; 27(12):603-5. PubMed ID: 1010749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous manifestations in multiple myeloma].
    Collet E; Dalac S; Guy H; Tavernier C; Lorcerie B; Besancenot JF; Escallier F; Lambert D
    Ann Dermatol Venereol; 1991; 118(1):35-44. PubMed ID: 2018305
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dermatological manifestations of monoclonal gammopathies: contribution of cutaneous histopathology].
    Lacoste C; Ingen-Housz-Oro S; Ortonne N
    Ann Pathol; 2015 Aug; 35(4):281-93. PubMed ID: 26188671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histological and pathogenetic spectrum of cutaneous disease in monoclonal gammopathies.
    Rongioletti F; Patterson JW; Rebora A
    J Cutan Pathol; 2008 Aug; 35(8):705-21. PubMed ID: 18331570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurologic aspects of plasma cell disorders.
    Sobol U; Stiff P
    Handb Clin Neurol; 2014; 120():1083-99. PubMed ID: 24365373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Skin diseases and monoclonal gammopathies].
    Kövary PM; Macher E
    Z Hautkr; 1979 Nov; 54(22):1002-7. PubMed ID: 539033
    [No Abstract]   [Full Text] [Related]  

  • 18. [Systemic Buschke's scleredema with cardiomyopathy, monoclonal IgG kappa gammopathy and amyloidosis. Case report with autopsy].
    Paz RA; Badra RE; Martí HM; Maxit MJ
    Medicina (B Aires); 1998; 58(5 Pt 1):501-3. PubMed ID: 9922484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal gammopathy of cutaneous significance: review of a relevant concept.
    Lipsker D
    J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):45-52. PubMed ID: 27501129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Skin disorders associated with monoclonal gammopathies].
    Houtman CJ; Genders RE; von dem Borne PA; Vermeer MH
    Ned Tijdschr Geneeskd; 2014; 158():A6717. PubMed ID: 24780569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.